Health • April 8, 2026
Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis
Originally published on Good News Network
A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world's leading cause of death from infectious disease. The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial survivors that can endure antibiotic treatment to spread another day. The paper on the
A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world's leading cause of death from infectious disease. The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial survivors that can endure antibiotic treatment to spread another day. The paper on the
Originally published on Good News Network.